Demographic parameters (missing data %) | Before propensity Score Matching | After propensity Score Matching | ||||
---|---|---|---|---|---|---|
CT group | Control group | P-value | CT group | Control group | P-value | |
Number of cycles | 731 | 1949 | Â | 670 | 670 | Â |
Age | 31.54 ± 4.18 | 30.99 ± 4.01 | 0.003 | 31.51 ± 4.22 | 31.66 ± 4.27 | 0.593 |
Body mass index | 21.91 ± 3.05 | 22.13 ± 3.05 | 0.046 | 21.91 ± 3.09 | 21.79 ± 2.97 | 0.645 |
Basal FSH (0.04%) | 7.78 ± 2.63 | 7.57 ± 2.44 | 0.234 | 7.78 ± 2.68 | 7.90 ± 2.77 | 0.275 |
Antra follicle count (0.15%) | 11.66 ± 6.45 | 13.62 ± 6.54 | < 0.001 | 11.66 ± 6.36 | 11.41 ± 5.88 | 0.454 |
Anti-Mullerian hormone (0.78%) | 3.13 ± 2.66 | 4.90 ± 3.88 | < 0.001 | 3.19 ± 2.71 | 3.19 ± 2.34 | 0.780 |
Primary/secondary infertility | 731 | 1949 | 0.295 | 670 | 638 | 0.730 |
primary, n% | 494 (67.58) | 1358 (69.68) | 447 (66.57) | 440 (65.67) | ||
secondary, n% | 237 (32.42) | 591 (30.32) | 223 (33.43) | 230 (34.33) | ||
Duration of infertility | 2.91 ± 2.21 | 3.37 ± 2.46 | < 0.001 | 2.99 ± 2.25 | 3.12 ± 2.20 | 0.157 |
Cause of infertility | Â | |||||
ovulation disorder, n% | 66 (9.03) | 341 (17.50) | < 0.001 | 63 (7.61) | 58 (8.66) | 0.699 |
Pelvic factor, n% | 339 (46.37) | 920 (47.20) | 0.702 | 307 (48.10) | 305 (45.52) | 0.955 |
Uterine factor, n% | 35 (4.79) | 178 (9.13) | < 0.001 | 35 (5.37) | 45 (6.72) | 0.289 |
Male factor, n% | 194 (26.54) | 589 (30.22) | 0.062 | 185 (28.21) | 175 (26.12) | 0.584 |
Endometriosis, n% | 64 (8.76) | 137 (7.03) | 0.131 | 58 (8.66) | 60 (8.96) | 0.923 |
Decreased ovarian reserve, n% | 133 (18.19) | 254 (13.03) | 0.001 | 120 (17.91) | 132 (19.70) | 0.432 |
Unexplained, n% | 78 (10.67) | 233 (11.95) | 0.355 | 76 (11.34) | 70 (10.45) | 0.653 |
Stimulation scheme | 731 | 1949 | < 0.001 | 670 | 670 | 0.799 |
short GnRH agonist protocol, n% | 71 (9.71) | 135 (6.93) | 71 (10.60) | 74 (11.04) | ||
GnRH antagonist protocol, n% | 483 (66.07) | 669 (34.33) | 422 (62.99) | 427 (63.73) | ||
long GnRH agonist protocol, n% | 174 (23.81) | 1130 (57.98) | 174(25.96) | 167 (24.93) | ||
mild stimulation or natural cycle protocol, n% | 3 (0.41) | 15 (0.76) | 3 (0.45) | 2 (0.30) | ||
Mean dose of Gonadotropin per day, IU | 260.63 ± 65.08 | 245.35 ± 75.05 | < 0.001 | 260.60 ± 66.20 | 263.72 ± 73.88 | 0.458 |
Endometrial thickness on the day of hCG injection, mm | 11.06 ± 2.21 | 11.72 ± 2.51 | < 0.001 | 11.13 ± 2.23 | 11.22 ± 2.39 | 0.724 |
Progesterone level on the day of hCG injection, ng/ml (0.15%) | 0.73 ± 0.36 | 0.69 ± 0.36 | 0.009 | 0.72 ± 0.37 | 0.72 ± 0.39 | 0.716 |
Manner of insemination (IVF/ICSI) | 731 | 1949 | 0.017 | 670 | 670 | 0.361 |
IVF, n% | 471 (64,43) | 1157 (59.36) | 419 (62.54) | 436 (65.07) | ||
ICSI, n% | 260 (35.57) | 792 (40.64) | 251 (37.46) | 234 (34.93) | ||
Number of embryos transferred | 731 | 1949 | 0.001 | 638 | 638 | 0.692 |
1, n% | 639 (87.41) | 1601 (82.14) | 578 (86.27) | 573 (85.52) | ||
2, n% | 92 (12.59) | 348 (17.86) | 92 (13.73) | 97 (14.48) |